DK1039905T3 - Farmaceutisk formulering omfattende glycin som en stabilisator - Google Patents

Farmaceutisk formulering omfattende glycin som en stabilisator

Info

Publication number
DK1039905T3
DK1039905T3 DK98957330T DK98957330T DK1039905T3 DK 1039905 T3 DK1039905 T3 DK 1039905T3 DK 98957330 T DK98957330 T DK 98957330T DK 98957330 T DK98957330 T DK 98957330T DK 1039905 T3 DK1039905 T3 DK 1039905T3
Authority
DK
Denmark
Prior art keywords
glycine
stabilizer
hours
pharmaceutical formulation
stable
Prior art date
Application number
DK98957330T
Other languages
English (en)
Inventor
Sumio Watanabe
Katsumi Onai
James Mcshane
Ray Wood
Kiyoshi Iwamoto
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DK1039905T3 publication Critical patent/DK1039905T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98957330T 1997-10-14 1998-09-14 Farmaceutisk formulering omfattende glycin som en stabilisator DK1039905T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6208997P 1997-10-14 1997-10-14

Publications (1)

Publication Number Publication Date
DK1039905T3 true DK1039905T3 (da) 2006-11-06

Family

ID=22040157

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98957330T DK1039905T3 (da) 1997-10-14 1998-09-14 Farmaceutisk formulering omfattende glycin som en stabilisator

Country Status (11)

Country Link
EP (1) EP1039905B1 (da)
JP (1) JP3459407B2 (da)
AT (1) ATE332133T1 (da)
AU (1) AU1361399A (da)
CA (1) CA2308143A1 (da)
CY (1) CY1106181T1 (da)
DE (1) DE69835165T2 (da)
DK (1) DK1039905T3 (da)
ES (1) ES2268800T3 (da)
PT (1) PT1039905E (da)
WO (1) WO1999018959A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1310252A4 (en) * 2000-08-18 2009-06-10 Takeda Pharmaceutical INJECTIONS
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
CA2480890A1 (en) * 2002-03-29 2003-10-09 Zeria Pharmaceutical Co., Ltd. 1-n-aminobenzimidazole derivatives
EP1660083A4 (en) * 2003-08-18 2009-03-25 Cadila Pharmaceuticals Ltd STABLE PHARMACEUTICAL COMPOSITION OF RABEPRAZOLE
DE102004007854A1 (de) * 2004-02-17 2005-09-01 Hexal Ag Stabile, wässrige Formulierung für Benzimidazole
CN104840431B (zh) * 2014-02-13 2017-09-08 长春海悦药业股份有限公司 一种含有伏立康唑的药物组合物
CN112807282A (zh) * 2021-01-13 2021-05-18 海南葫芦娃药业集团股份有限公司 一种奥美拉唑钠冻干粉针剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5610110A (en) * 1979-07-06 1981-02-02 Green Cross Corp:The Acetyl salicylate salt preparation for injection
JPS5665816A (en) * 1979-11-01 1981-06-03 Green Cross Corp:The Acetylsalicylate pharmaceutical for injection
DE3262575D1 (en) * 1981-12-23 1985-04-18 Schering Corp Stabilised interferon formulations and their preparation
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
JPH0594225A (ja) * 1991-09-30 1993-04-16 Toshiba Corp セキユリテイ機能を内蔵したパーソナルコンピユータ
JPH05194225A (ja) * 1991-11-07 1993-08-03 Yoshitomi Pharmaceut Ind Ltd 安定化された抗潰瘍剤含有製剤
US6270757B1 (en) * 1994-04-21 2001-08-07 Genetics Institute, Inc. Formulations for IL-11

Also Published As

Publication number Publication date
ES2268800T3 (es) 2007-03-16
WO1999018959A9 (en) 1999-08-05
EP1039905B1 (en) 2006-07-05
AU1361399A (en) 1999-05-03
DE69835165D1 (de) 2006-08-17
WO1999018959A1 (en) 1999-04-22
EP1039905A1 (en) 2000-10-04
DE69835165T2 (de) 2007-06-06
ATE332133T1 (de) 2006-07-15
CY1106181T1 (el) 2011-06-08
JP2001519390A (ja) 2001-10-23
JP3459407B2 (ja) 2003-10-20
CA2308143A1 (en) 1999-04-22
PT1039905E (pt) 2006-11-30

Similar Documents

Publication Publication Date Title
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
PL319603A1 (en) Stable aqueous alpha interferon preparations
KR950703987A (ko) G-csf의 안정한 동결건조된 약제학적 제제(stable lyophilized pharma ceutical preparations g-csf)
MY120984A (en) Activated protein c formulations
CA2400318A1 (en) Botulinum toxin pharmaceutical compositions
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
NO883926D0 (no) Fremgangsmaate for fremstilling av stabilisert humanproteinpreparat.
BR0307893A (pt) Formulação oftálmica com sistema de goma
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
CA2226548A1 (en) Lyophilized hepatocyte growth factor preparations
ES2177323T3 (es) Preparaciones de insulina concentradas estables para la administracionpor via pulmonar.
DK1039905T3 (da) Farmaceutisk formulering omfattende glycin som en stabilisator
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
ATE345139T1 (de) Karzinostatische wirkstoffe
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
KR950005325A (ko) 제약 조성물
CA2041989A1 (en) Aqueous pharmaceutical formulations of erythropoietin and the use thereof
WO2000051603A3 (en) Compositions of remifentanil
JPS62120321A (ja) tPA含有医薬組成物
DK1204676T3 (da) Streptograminderivater, deres fremstilling samt præparater indeholdende disse derivater
SE9502927D0 (sv) Solution containing IGF-I
IT1247752B (it) Composizioni farmaceutiche aventi come principio attivo calcitonina da somministrarsi per via intranasale.